Tianjin Medical Journal ›› 2025, Vol. 53 ›› Issue (4): 402-406.doi: 10.11958/20242154
• Clinical Research • Previous Articles Next Articles
FAN Yongjun1(), LIU Wenfang1, LU Yachao2
Received:
2024-12-08
Revised:
2025-02-26
Published:
2025-04-15
Online:
2025-04-17
FAN Yongjun, LIU Wenfang, LU Yachao. Relationship between ventricular arterial coupling and haemodynamics in patients with sepsis and its predictive value for prognosis[J]. Tianjin Medical Journal, 2025, 53(4): 402-406.
CLC Number:
时间 | Ea/Ees | CVP/mmHg | SVI/mL | CI/[L/(min·m2)] |
---|---|---|---|---|
0 h | 1.25±0.12 | 4.16±1.73 | 23.19±3.21 | 4.58±1.12 |
24 h | 1.21±0.14a | 6.21±1.75a | 27.89±3.32a | 5.26±1.15a |
72 h | 1.16±0.16ab | 5.53±1.73ab | 26.37±3.27ab | 4.93±1.12ab |
F主效应 | 16.785** | 59.285** | 88.385** | 14.849** |
Tab.1 复苏0 h、24 h、72 h的Ea/Ees及血流动力学参数比较 (n=164,$\bar{x} \pm s$)
时间 | Ea/Ees | CVP/mmHg | SVI/mL | CI/[L/(min·m2)] |
---|---|---|---|---|
0 h | 1.25±0.12 | 4.16±1.73 | 23.19±3.21 | 4.58±1.12 |
24 h | 1.21±0.14a | 6.21±1.75a | 27.89±3.32a | 5.26±1.15a |
72 h | 1.16±0.16ab | 5.53±1.73ab | 26.37±3.27ab | 4.93±1.12ab |
F主效应 | 16.785** | 59.285** | 88.385** | 14.849** |
时间 | ΔEa/Ees | ΔCVP/ mmHg | ΔSVI/ mL | ΔCI/[L/ (min·m2)] |
---|---|---|---|---|
24 h | -0.08(-0.11,0.03) | 2.05±0.23 | 4.70±0.84 | 0.67±0.17 |
72 h | -0.11(-0.15,0.02) | 1.37±0.20 | 3.17±0.68 | 0.35±0.08 |
Z或t | 7.024** | 16.912** | 10.560** | 11.614** |
Tab.2 复苏0 h、24 h、72 h的Ea/Ees及血流动力学参数变化情况比较
时间 | ΔEa/Ees | ΔCVP/ mmHg | ΔSVI/ mL | ΔCI/[L/ (min·m2)] |
---|---|---|---|---|
24 h | -0.08(-0.11,0.03) | 2.05±0.23 | 4.70±0.84 | 0.67±0.17 |
72 h | -0.11(-0.15,0.02) | 1.37±0.20 | 3.17±0.68 | 0.35±0.08 |
Z或t | 7.024** | 16.912** | 10.560** | 11.614** |
指标 | 24 hΔEa/Ees | 指标 | 72 hΔEa/Ees | |
---|---|---|---|---|
24 hΔCVP | -0.654** | 72 hΔCVP | -0.046 | |
24 hΔSVI | -0.567** | 72 hΔSVI | -0.082 | |
24 hΔCI | -0.451** | 72 hΔCI | -0.073 |
Tab.3 Ea/Ees与脓毒症患者血流动力学指标的相关性分析 (rs)
指标 | 24 hΔEa/Ees | 指标 | 72 hΔEa/Ees | |
---|---|---|---|---|
24 hΔCVP | -0.654** | 72 hΔCVP | -0.046 | |
24 hΔSVI | -0.567** | 72 hΔSVI | -0.082 | |
24 hΔCI | -0.451** | 72 hΔCI | -0.073 |
组别 | n | 年龄/岁 | 性别(男/女) | BMI/(kg/m2) | 基础疾病 | 感染部位 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
高血压 | 高脂血症 | 糖尿病 | 冠心病 | 肺部 | 腹部 | 血流 | 其他 | |||||||||||
存活组 | 123 | 62.75±3.48 | 66/57 | 23.23±1.56 | 51 | 39 | 35 | 28 | 41 | 35 | 28 | 19 | ||||||
死亡组 | 41 | 63.59±3.65 | 23/18 | 23.45±1.69 | 18 | 15 | 14 | 11 | 16 | 11 | 8 | 6 | ||||||
t或χ2 | 1.319 | 0.074 | 0.729 | 0.075 | 0.331 | 0.475 | 0.280 | 0.477 | ||||||||||
组别 | 吸烟史 | 饮酒史 | 血管活性药物 | APACHEⅡ(≥20分/<20分) | SOFA(≥10分/<10分) | 24 hΔEa/Ees | 72 hΔEa/Ees | |||||||||||
存活组 | 73 | 67 | 63 | 52/71 | 55/68 | -0.10±0.03 | -0.14±0.05 | |||||||||||
死亡组 | 27 | 23 | 26 | 26/15 | 27/14 | 0.15±0.05 | 0.18±0.07 | |||||||||||
χ2或t | 0.547 | 0.033 | 1.843 | 5.509* | 5.496* | 38.523** | 31.909** |
Tab.4 存活组与死亡组患者基线资料及Ea/Ees指标比较
组别 | n | 年龄/岁 | 性别(男/女) | BMI/(kg/m2) | 基础疾病 | 感染部位 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
高血压 | 高脂血症 | 糖尿病 | 冠心病 | 肺部 | 腹部 | 血流 | 其他 | |||||||||||
存活组 | 123 | 62.75±3.48 | 66/57 | 23.23±1.56 | 51 | 39 | 35 | 28 | 41 | 35 | 28 | 19 | ||||||
死亡组 | 41 | 63.59±3.65 | 23/18 | 23.45±1.69 | 18 | 15 | 14 | 11 | 16 | 11 | 8 | 6 | ||||||
t或χ2 | 1.319 | 0.074 | 0.729 | 0.075 | 0.331 | 0.475 | 0.280 | 0.477 | ||||||||||
组别 | 吸烟史 | 饮酒史 | 血管活性药物 | APACHEⅡ(≥20分/<20分) | SOFA(≥10分/<10分) | 24 hΔEa/Ees | 72 hΔEa/Ees | |||||||||||
存活组 | 73 | 67 | 63 | 52/71 | 55/68 | -0.10±0.03 | -0.14±0.05 | |||||||||||
死亡组 | 27 | 23 | 26 | 26/15 | 27/14 | 0.15±0.05 | 0.18±0.07 | |||||||||||
χ2或t | 0.547 | 0.033 | 1.843 | 5.509* | 5.496* | 38.523** | 31.909** |
因素 | β | SE | Wald χ2 | P | HR | HR 95%CI |
---|---|---|---|---|---|---|
APACHEⅡ | 1.131 | 0.330 | 11.770 | 0.001 | 3.099 | 1.624~5.914 |
SOFA | 0.700 | 0.225 | 9.664 | 0.002 | 2.013 | 1.295~3.129 |
24 hΔEa/Ees | 1.259 | 0.366 | 11.855 | 0.001 | 3.522 | 1.720~7.212 |
72 hΔEa/Ees | 0.690 | 0.236 | 8.541 | 0.003 | 1.993 | 1.255~3.165 |
Tab.5 脓毒症患者28 d预后不良的多因素Cox回归分析
因素 | β | SE | Wald χ2 | P | HR | HR 95%CI |
---|---|---|---|---|---|---|
APACHEⅡ | 1.131 | 0.330 | 11.770 | 0.001 | 3.099 | 1.624~5.914 |
SOFA | 0.700 | 0.225 | 9.664 | 0.002 | 2.013 | 1.295~3.129 |
24 hΔEa/Ees | 1.259 | 0.366 | 11.855 | 0.001 | 3.522 | 1.720~7.212 |
72 hΔEa/Ees | 0.690 | 0.236 | 8.541 | 0.003 | 1.993 | 1.255~3.165 |
指标 | AUC(95%CI) | 截断值 | 敏感度/ % | 特异度/ % | 约登 指数 |
---|---|---|---|---|---|
APACHEⅡ | 0.613(0.521~0.699) | 20分 | 63.41 | 57.72 | 0.226 |
SOFA | 0.602(0.510~0.689) | 10分 | 65.85 | 55.28 | 0.204 |
24 hΔEa/Ees | 0.798(0.717~0.865) | 0.12 | 85.32 | 74.58 | 0.570 |
72 hΔEa/Ees | 0.811(0.731~0.876) | 0.17 | 75.17 | 77.93 | 0.516 |
Tab.6 APACHEⅡ、SOFA、24 hΔEa/Ees以及72 hΔEa/Ees对脓毒症患者28 d预后的预测价值
指标 | AUC(95%CI) | 截断值 | 敏感度/ % | 特异度/ % | 约登 指数 |
---|---|---|---|---|---|
APACHEⅡ | 0.613(0.521~0.699) | 20分 | 63.41 | 57.72 | 0.226 |
SOFA | 0.602(0.510~0.689) | 10分 | 65.85 | 55.28 | 0.204 |
24 hΔEa/Ees | 0.798(0.717~0.865) | 0.12 | 85.32 | 74.58 | 0.570 |
72 hΔEa/Ees | 0.811(0.731~0.876) | 0.17 | 75.17 | 77.93 | 0.516 |
[1] | 赵奕琳, 刘田恬, 王春霞. 外泌体参与脓毒症发生发展及临床诊治方面的研究进展[J]. 中华危重病急救医学, 2024, 36(2):221-224. |
ZHAO Y L, LIU T T, WANG C X. Research advances in exosomes involved in the occurrence,development and clinical diagnosis and treatment of sepsis[J]. Chin Crit Care Med, 2024, 36(2):221-224. doi:10.3760/cma.j.cn121430-20230809-00601. | |
[2] | FORD V J, APPLEFELD W N, WANG J, et al. Cardiac magnetic resonance studies in a large animal model that simulates the cardiac abnormalities of human septic shock[J]. J Am Heart Assoc, 2024, 13(15):e034026. doi:10.1161/JAHA.123.034026. |
[3] | 王小燕, 朱雪峰, 陆赵阳, 等. 超声二维斑点追踪成像技术对尿毒症患者心室动脉偶联情况的评估价值[J]. 天津医药, 2021, 49(11):1203-1206. |
WANG X Y, ZHU X F, LU Z Y, et al. The predictive value of two-dimensional ultrasonic speckle tracking imaging technology for ventricular arterial coupling in uremic patients[J]. Tianjin Med J, 2021, 49(11):1203-1206. doi:10.11958/20203570. | |
[4] | 欧阳秋芳, 游涛, 许荣, 等. 健心颗粒通过调控Apelin通路对心力衰竭大鼠心室-动脉偶联的影响[J]. 中成药, 2024, 46(1):262-267. |
OUYANG Q F, YOU T, XU R, et al. Effect of heart-healthy granules on ventricular-arterial coupling in heart failure rats through modulation of the Apelin pathway[J]. Chinese Traditional Patent Medicine, 2024, 46(1):262-267. doi:10.3969/j.issn.1001-1528.2024.01.045. | |
[5] | ZHOU X, PAN J, WANG Y, et al. Left ventricular-arterial coupling as a predictor of stroke volume response to norepinephrine in septic shock - a prospective cohort study[J]. BMC Anesthesiol, 2021, 21(1):56. doi:10.1186/s12871-021-01276-y. |
[6] | DEMAILLY Z, BESNIER E, TAMION F, et al. Ventriculo-arterial (un)coupling in septic shock:impact of current and upcoming hemodynamic drugs[J]. Front Cardiovasc Med, 2023,10:1172703. doi:10.3389/fcvm.2023.1172703. |
[7] | 中国医师协会急诊医师分会, 中国研究型医院学会休克与脓毒症专业委员会. 中国脓毒症/脓毒性休克急诊治疗指南(2018)[J]. 中国急救医学, 2018, 38(9):741-756. |
Emergency Physicians Branch of Chinese Physicians Association,Shock and Sepsis Committee of Chinese Society of Research Hospitals. Chinese guidelines for emergency treatment of sepsis/septic shock (2018)[J]. Chin J Crit Care Meb, 2018, 38(9):741-756. doi:10.3969/j.issn.1002-1949.2018.09.001. | |
[8] | RANJIT S, KISSOON N, ARGENT A, et al. Haemodynamic support for paediatric septic shock:a global perspective[J]. Lancet Child Adolesc Health, 2023, 7(8):588-598. doi:10.1016/S2352-4642(23)00103-7. |
[9] | LIAN H, LI S, ZHANG Q, et al. U-shaped prognostic value of left ventricular-arterial coupling in septic patients:a prospective study[J]. Eur J Med Res, 2024, 29(1):435. doi:10.1186/s40001-024-02037-6. |
[10] | 黄玉慧, 张岩, 范春芝, 等. 肾动脉阻力指数联合肺动脉高压对脓毒症患者死亡风险的预测价值[J]. 军事医学, 2024, 48(3):225-229. |
HUANG Y H, ZHANG Y, FAN C Z, et al. Renal resistive index combined with pulmonary hypertension in assessing mortality risk in sepsis patients[J]. Mil Med Sei, 2024, 48(3):225-229. doi:10.7644/j.issn.1674-9960.2024.03.010. | |
[11] | 黄浩, 陈湘平, 李程锦, 等. 革兰阴性杆菌感染脓毒症患者B型利钠肽水平与血流动力学参数及炎性因子的相关性[J]. 中国医学科学院学报, 2021, 43(6):879-885. |
HUANG H, CHEN X P, LI C J, et al. Correlation of B-type natriuretic peptide level with hemodynamic parameters and inflammatory cytokines in patients with gram-negative sepsis[J]. Acta Academiae Medicinae Sinicae, 2021, 43(6):879-885. doi:10.3881/j.issn.1000-503X.14022. | |
[12] | 董倩倩, 杨燕, 刘德智. 血流动力学参数与脓毒症休克患者容量反应性的预测及相关性分析[J]. 医用生物力学, 2023, 38(6):1219-1225. |
DONG Q Q, YANG Y, LIU D Z. Prediction and correlation analysis of hemodynamic parameters and volume responsiveness in patients with septic shock[J]. Journal of Medical Biomechanics, 2023, 38(6):1219-1225. doi:10.16156/j.1004-7220.2023.06.025. | |
[13] | NASU M, SATO R, TAKAHASHI K, et al. The chronological demographics of ventricular-arterial decoupling in patients with sepsis and septic shock:a prospective observational study[J]. J Intensive Care Med, 2023, 38(4):340-348. doi:10.1177/08850666221120219. |
[14] | YOU J Y, SATO R, CHAWLA S, et al. Hemodynamic profile of cirrhotic patients with sepsis and septic shock:a propensity score matched case-control study[J]. J Crit Care, 2024,81:154532. doi:10.1016/j.jcrc.2024.154532. |
[15] | MESSINA A, CALABRÒ L, PUGLIESE L, et al. Fluid challenge in critically ill patients receiving haemodynamic monitoring:a systematic review and comparison of two decades[J]. Crit Care, 2022, 26(1):186. doi:10.1186/s13054-022-04056-3. |
[16] | ZHOU X, ZHANG Y, PAN J, et al. Optimizing left ventricular-arterial coupling during the initial resuscitation in septic shock - a pilot prospective randomized study[J]. BMC Anesthesiol, 2022, 22(1):31. doi:10.1186/s12871-021-01553-w. |
[17] | KATTAN E, BAKKER J, ESTENSSORO E, et al. Hemodynamic phenotype-based,capillary refill time-targeted resuscitation in early septic shock:the ANDROMEDA-SHOCK-2 Randomized Clinical Trial study protocol[J]. Rev Bras Ter Intensiva, 2022, 34(1):96-106. doi:10.5935/0103-507X.20220004-pt. |
[18] | MA Q, DING C, WEI W, et al. The value of right ventricular pulmonary artery coupling in determining the prognosis of patients with sepsis[J]. Sci Rep, 2024, 14(1):15283. doi:10.1038/s41598-024-65738-2. |
[19] | QIU X, LEI Y P, ZHOU R X. SIRS,SOFA,qSOFA,and NEWS in the diagnosis of sepsis and prediction of adverse outcomes:a systematic review and meta-analysis[J]. Expert Rev Anti Infect Ther, 2023, 21(8):891-900. doi:10.1080/14787210.2023.2237192. |
[20] | BOWCOCK E M, GERHARDY B, HUANG S, et al. Right ventricular outflow tract Doppler flow analysis and pulmonary arterial coupling by transthoracic echocardiography in sepsis:a retrospective exploratory study[J]. Crit Care, 2022, 26(1):303. doi:10.1186/s13054-022-04160-4. |
[1] | WANG Caili, WANG Rui, GUO Lining. The expression level and clinical value of ALKBH5 and PAK5 in high-risk HPV positive cervical cancer tissue [J]. Tianjin Medical Journal, 2025, 53(4): 355-359. |
[2] | MIAO Yan, ZHU Lei, FAN Yuanhui. Effect of remimazolam on recovery quality of children with strabismus surgery under general anesthesia [J]. Tianjin Medical Journal, 2025, 53(4): 425-428. |
[3] | ZHANG Yuxuan, LIU Yidan, CHEN Zhe, ZHANG Wen, LI Ruixuan, YAN Qiang, XU Guiping. The predictive value of serum HMGB1 and sRAGE in the occurrence and short-term prognosis of sepsis-associated encephalopathy [J]. Tianjin Medical Journal, 2025, 53(3): 262-266. |
[4] | ZHONG Chongwen, TANG Dezheng. The predictive value of serum CTRP3 and YKL-40 for implant prognosis in patients undergoing oral implant restoration [J]. Tianjin Medical Journal, 2025, 53(3): 292-296. |
[5] | NI Man, GE Jun, KONG Ziang. Correlation analysis of HMGB1 and MCP-1 levels and prognosis of patients with sepsis combined with AKI [J]. Tianjin Medical Journal, 2025, 53(3): 297-301. |
[6] | JU Feng, ZHAO Guangyu, LIU Yin, JIANG Xin, YIN Dengyang, GU Hong. The prognostic value of serum IFN-γ, MBL and sFas expression levels in patients with multiple myeloma [J]. Tianjin Medical Journal, 2025, 53(2): 141-145. |
[7] | WU Jingjing, ZHANG Fusen, CHEN Hao, ZHAO Yi, LIU Quan, LI Dongmei. Application value of serum Syndecan-1, endocan-1 and qSOFA scores in diagnosis and prognosis of sepsis [J]. Tianjin Medical Journal, 2025, 53(2): 185-188. |
[8] | WANG Xiaoya, ZHANG Min, HE Xiaogang. Clinical study of pentoxifylline combined with edaravone dextrocamphenol in the treatment of acute cerebral infarction [J]. Tianjin Medical Journal, 2025, 53(2): 208-212. |
[9] | WU Yameng, LI Liangliang, WANG Yangang, XING Defu. Predictive value of serum APOC1 and Klotho expression for prognosis in patients undergoing laparoscopic partial nephrectomy for renal cancer [J]. Tianjin Medical Journal, 2025, 53(1): 61-64. |
[10] | SONG Hu, ZHU Jian, FU Yongmei, ZHANG Yongbiao, ZHENG Changlong. The value of combined detection of PCT, IL-6 and CysC for the diagnosis and prognosis assessment of septic acute kidney injury [J]. Tianjin Medical Journal, 2025, 53(1): 65-70. |
[11] | JIA Weining, BAO Yaling, LEI Hui, YIN Xiaoning. The effect of prunella vulgaris extract on inflammatory response and peritoneal macrophages in septic mice [J]. Tianjin Medical Journal, 2024, 52(9): 930-935. |
[12] | YANG Min, PAN Yansha, ZHANG Changling, CHEN Hongying, GUO Qulian, LIU Wenjun. Correlation analysis of baseline data, early treatment response and prognosis in children with acute lymphoblastic leukemia [J]. Tianjin Medical Journal, 2024, 52(9): 954-958. |
[13] | WANG Xinbo, LUO Bingqing, SHI Yubao, ZHANG Ye, XI Jiangwei. Expression of LncRNA LINC00342 and miR-203a-3p in colorectal cancer tissue and their relationship with prognosis [J]. Tianjin Medical Journal, 2024, 52(9): 971-976. |
[14] | DAI Yao, FANG Xiang, HUANG Kang, FENG Jie, LIU Min, WU Songbai. Clinical curative effect of HAT therapy on septic shock [J]. Tianjin Medical Journal, 2024, 52(8): 825-829. |
[15] | ZHANG Xiyou, GUO Yidan, ZHANG Chunxia, ZHOU Xiaoling, JIA Meng, SHI Zhihua, LUO Yang. Clinical research of the correlation between hyperkalemia and adverse outcome events in elderly patients with maintenance hemodialysis [J]. Tianjin Medical Journal, 2024, 52(8): 840-844. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||